Mice Live Longer on Magic Mushrooms
August 22, 2025
Study supports systemic anti-aging potential of psilocybin
2 min read
False
Advertisement
Small Molecules
Isotopic Fingerprints: A Forensic Frontier for Drug Product Authentication
August 18, 2025
Stable isotope ratio mass spectrometry used to assess drug authenticity and consistency.
3 min read
Shaping Drug Discovery with AI
August 15, 2025
A consortium of organizations is looking to set new precedents in compound discovery, validation, and clinical success for patients with delayed cerebral ischemia.
4 min read
Rewiring the Brain: A Dual-Drug Strategy to Tackle Alzheimer’s Disease
August 14, 2025
A tale of two cancer drugs: Study suggests that repurposing letrozole and irinotecan can restore memory and reverse pathology in Alzheimer’s model.
3 min read
Discovery Strategies for Oligonucleotides
By Stephanie Vine
August 14, 2025
Targeting disease at the genetic level isn’t science fiction – it’s oligonucleotides. Hilary Brooks reveals how smarter discovery strategies are reshaping what’s possible in drug development.
10 min read
Abivax on Phase III Strategy
August 12, 2025
As obefazimod reports positive phase III results, we discuss the strategic decisions that fueled rapid trial enrollment and how the groundwork is being laid for a potential market launch.
5 min read
An Oral Approach for Diabetic Retinopathy
By Rob Coker
August 5, 2025
How a small molecule drug originally developed for cardiac arrhythmia could become a non-invasive treatment option for diabetic retinopathy.
3 min read
Understanding the Role of TRPV1 in Small Molecule Treatments for Obesity and Diabetes
August 4, 2025
Step aside, GLP-1 biologics – there’s a smaller kid in town. Meet the clinical stage Nordic company developing a small molecule TRPV1 antagonist for weight loss and diabetes treatment.
8 min read
The Power List Personified: Getting to Know Kevin Kreutter
July 17, 2025
Learning more about the people behind the 2025 Power List.
4 min read
Pramipexole’s Potential in Depression Therapy
By Rob Coker
July 16, 2025
An Oxford University-led study has found that the Parkinson’s drug pramipexole might be just the dopamine boost that treatment-resistant depression has been waiting for.
3 min read
